Latest filing published 26 Jun 2026 for Journey Medical Corp. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Neil Herskowitz (board member) discloses dealings in 4 companies, chiefly Journey Medical Corp, Checkpoint Therapeutics, Inc. and Mustang Bio, Inc. Over a trading history stretching from 6 May 2021 to 25 June 2026, the count stands at 20 filings.
The open-market side counts 1 purchase for €8,265 alongside 2 sales for €245. Netting one side against the other leaves €8,020 of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 17 share grants.
The newest entry dates from 26 June 2026: a share grant, in Journey Medical Corp. The latest purchase dates back some time: it was published 1,990 days ago, on 7 May 2021. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations